Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer.
Subudhi SK, Vence L, Zhao H, Blando J, Yadav SS, Xiong Q, Reuben A, Aparicio A, Corn PG, Chapin BF, Pisters LL, Troncoso P, Tidwell RS, Thall P, Wu CJ, Zhang J, Logothetis CL, Futreal A, Allison JP, Sharma P.
Subudhi SK, et al. Among authors: sharma p.
Sci Transl Med. 2020 Apr 1;12(537):eaaz3577. doi: 10.1126/scitranslmed.aaz3577.
Sci Transl Med. 2020.
PMID: 32238575
Clinical Trial.